242 related articles for article (PubMed ID: 18077326)
1. The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.
Weiske J; Albring KF; Huber O
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20344-9. PubMed ID: 18077326
[TBL] [Abstract][Full Text] [Related]
2. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
[TBL] [Abstract][Full Text] [Related]
3. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
4. A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1.
Boylston JA; Brenner C
Cell Cycle; 2014; 13(18):2913-30. PubMed ID: 25486479
[TBL] [Abstract][Full Text] [Related]
5. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract][Full Text] [Related]
6. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
7. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit.
Hacker SM; Mortensen F; Scheffner M; Marx A
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10247-50. PubMed ID: 25098403
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the role of Fhit in suppression of DNA damage.
Saldivar JC; Bene J; Hosseini SA; Miuma S; Horton S; Heerema NA; Huebner K
Adv Biol Regul; 2013 Jan; 53(1):77-85. PubMed ID: 23102829
[TBL] [Abstract][Full Text] [Related]
9. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
[TBL] [Abstract][Full Text] [Related]
10. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
Yutori H; Semba S; Komori T; Yokozaki H
Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
[TBL] [Abstract][Full Text] [Related]
11. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
Zawacka-Pankau J; Podhajska AJ
Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
[TBL] [Abstract][Full Text] [Related]
12. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells.
Deng WG; Nishizaki M; Fang B; Roth JA; Ji L
Biochem Biophys Res Commun; 2007 Apr; 355(4):993-9. PubMed ID: 17328863
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
15. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
16. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor protein Fhit. A novel interaction with tubulin.
Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
[TBL] [Abstract][Full Text] [Related]
18. Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.
Zuo H; Chan GP; Zhu J; Yeung WW; Chan AS; Ammer H; Wong YH
Cell Commun Signal; 2013 Aug; 11():59. PubMed ID: 23947369
[TBL] [Abstract][Full Text] [Related]
19. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma.
Koch E; Fiedler W; Tannapfel A; Ballhausen WG
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):907-13. PubMed ID: 12867802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
